FDA Approves Gemcitabine Intravesical System for Non-Muscle Invasive Bladder Cancer By Ogkologos - September 19, 2025 524 0 Facebook Twitter Google+ Pinterest WhatsApp Evidence for efficacy is based on the results from the Cohort 2 of SunRISe-1 study Source RELATED ARTICLESMORE FROM AUTHOR New Targeted Therapy Shows Promising Early Results in Advanced Pancreatic Cancer FDA Approves Pivekimab Sunirine-pvzy for Blastic Plasmacytoid Dendritic Cell Neoplasm, an Ultra-Rare Haematologic Malignancy Ivonescimab Plus Chemotherapy Improves OS Compared with Tislelizumab Plus Chemotherapy in Previously Untreated Patients with Advanced Squamous NSCLC MOST POPULAR Inequalities cause 2,000 extra cancer cases in Wales June 8, 2023 Solid Organ Transplant Recipients with Pretransplant Cancer Have an Elevated Risk... March 30, 2026 Adjuvant Pembrolizumab Continues to Demonstrate a Clinically Meaningful DMFS Benefit in... March 14, 2024 Cancer in My Community: Bringing Palliative Care to People With Cancer... February 21, 2023 Load more HOT NEWS Cancer Surgery Unexpectedly Canceled for Mother of Two, Who Says It’s... When Both Tumour-Infiltrating Lymphocytes and Gene Expression are Available, the Prognostic... Patient Guide in Colorectal Cancer Now Available in Bulgarian The link between Down syndrome and childhood leukaemia
